Back to overview
Back to overview

Primary results from the SAUL study

Prof. Jens Bedke (DE) and Prof. Maria José Ribal discussed the primary results from the SAUL study with Prof. Axel Merseburger (DE). SAUL is a prospective multinational single-arm study of atezolizumab (atezo) for locally advanced or metastatic urothelial carcinoma (UC) or non-UC of the urinary tract.

Read the written report about the study here.

Categories

18 December 2024

Learn, lead, compete: EAU25’s exciting educational activities for you

“The future belongs to those who learn more skills and adapt to the changing times.” This Abraham Lincoln quote reflects
09 December 2024

AI-powered live translation to be offered at EAU25

The EAU is proud to offer, for the first time at an Annual Congress, live translation for almost every session.